• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用促性腺激素释放激素激动剂亮丙瑞林对多毛女性睾酮和雌二醇的差异性抑制作用

Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.

作者信息

Rittmaster R S

机构信息

Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

出版信息

J Clin Endocrinol Metab. 1988 Oct;67(4):651-5. doi: 10.1210/jcem-67-4-651.

DOI:10.1210/jcem-67-4-651
PMID:3138274
Abstract

To determine the dose of the GnRH agonist leuprolide necessary to maximally suppress ovarian testosterone secretion, 10 moderately to severely hirsute women (5 with idiopathic hirsutism and 5 with polycystic ovarian syndrome) were given gradually increasing leuprolide doses, starting with either 5 or 10 micrograms/kg.day. Serum testosterone and estradiol, basal LH, and the LH response to GnRH were measured before and at the end of each treatment period, until maximal suppression of estradiol and testosterone occurred. Leuprolide was then continued for a total of 6 months to assess its clinical efficacy. Hirsutism scores and hair growth rates were determined before and after therapy. Serum estradiol and the LH response to GnRH were maximally or near-maximally suppressed in all women by the lowest doses of leuprolide used. Basal serum LH was not maximally suppressed in all women until a dose of 15 micrograms/kg.day was reached, and maximal testosterone suppression required 15 micrograms/kg.day or more in 7 of the 10 women. The addition of 0.5 mg dexamethasone daily for 4 weeks at the end of the study in 5 of the women reduced serum testosterone to undetectable levels. Symptomatic improvement in hirsutism occurred in 9 women, hirsutism scores decreased by at least 3 points in 5 women, and hair growth rates decreased in 8 women. These data indicate that low doses of leuprolide were sufficient to maximally suppress serum estradiol and the LH response to exogenous GnRH. Higher leuprolide doses were needed to maximally suppress serum testosterone and the basal LH levels. Leuprolide (20 micrograms/kg.day) effectively reduced hair growth in the majority of these women.

摘要

为确定能最大程度抑制卵巢睾酮分泌所需的促性腺激素释放激素(GnRH)激动剂亮丙瑞林的剂量,对10名中度至重度多毛女性(5名特发性多毛症患者和5名多囊卵巢综合征患者)给予逐渐增加剂量的亮丙瑞林,起始剂量为5或10微克/千克·天。在每个治疗期开始前及结束时测量血清睾酮、雌二醇、基础促黄体生成素(LH)以及LH对GnRH的反应,直至雌二醇和睾酮受到最大程度抑制。然后持续使用亮丙瑞林共6个月以评估其临床疗效。在治疗前后测定多毛症评分和头发生长速率。使用的最低剂量亮丙瑞林可使所有女性的血清雌二醇和LH对GnRH的反应受到最大程度或接近最大程度的抑制。直到达到15微克/千克·天的剂量,所有女性的基础血清LH才受到最大程度抑制,10名女性中有7名最大程度抑制睾酮需要15微克/千克·天或更高剂量。在研究结束时,5名女性每天加用0.5毫克地塞米松,持续4周,可使血清睾酮降至检测不到的水平。9名女性的多毛症症状有所改善,5名女性的多毛症评分至少降低了3分,8名女性的头发生长速率下降。这些数据表明,低剂量亮丙瑞林足以最大程度抑制血清雌二醇和LH对外源性GnRH的反应。需要更高剂量的亮丙瑞林才能最大程度抑制血清睾酮和基础LH水平。亮丙瑞林(20微克/千克·天)可有效减少这些女性中的大多数人的毛发生长。

相似文献

1
Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.使用促性腺激素释放激素激动剂亮丙瑞林对多毛女性睾酮和雌二醇的差异性抑制作用
J Clin Endocrinol Metab. 1988 Oct;67(4):651-5. doi: 10.1210/jcem-67-4-651.
2
Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.亮丙瑞林和地塞米松对多毛症女性毛发生长及激素水平的影响:卵巢和肾上腺在多毛症发病机制中的相对重要性
J Clin Endocrinol Metab. 1990 Apr;70(4):1096-102. doi: 10.1210/jcem-70-4-1096.
3
Treatment of hirsutism with a gonadotropin-releasing hormone agonist (nafarelin).
J Clin Endocrinol Metab. 1986 Oct;63(4):854-9. doi: 10.1210/jcem-63-4-854.
4
Dose-response effect of depot leuprolide acetate on serum androgens in hirsute women.
Fertil Steril. 1996 May;65(5):912-5. doi: 10.1016/s0015-0282(16)58259-4.
5
Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.口服避孕药、促性腺激素释放激素激动剂或联合使用治疗多毛症:一项临床研究中心的研究。
J Clin Endocrinol Metab. 1995 Apr;80(4):1169-78. doi: 10.1210/jcem.80.4.7714086.
6
Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.亮丙瑞林与雌激素对比口服避孕药治疗多毛症:一项前瞻性随机研究
J Clin Endocrinol Metab. 1995 Dec;80(12):3406-11. doi: 10.1210/jcem.80.12.8530573.
7
Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.慢性促性腺激素释放激动剂给药后多囊卵巢疾病的口服避孕药治疗。持续卵巢抑制的预测因素。
J Reprod Med. 1996 Sep;41(9):645-52.
8
Obesity affects circulating estradiol levels of premenopausal hirsute women receiving leuprolide acetate depot.
Int J Fertil Menopausal Stud. 1993 May-Jun;38(3):139-46.
9
Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study.促性腺激素释放激素激动剂亮丙瑞林的急性激素反应:剂量反应研究及与那法瑞林的比较——一项临床研究中心研究
J Clin Endocrinol Metab. 1996 Sep;81(9):3408-11. doi: 10.1210/jcem.81.9.8784105.
10
Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism.
Exp Clin Endocrinol Diabetes. 1995;103(1):15-20. doi: 10.1055/s-0029-1211324.

引用本文的文献

1
Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women.内分泌学会女性雄激素过多评估临床实践指南
Clin Endocrinol (Oxf). 2025 Oct;103(4):540-566. doi: 10.1111/cen.15265. Epub 2025 May 13.
2
The role of luteinizing hormone activity in controlled ovarian stimulation.促黄体生成素活性在控制性卵巢刺激中的作用。
J Endocrinol Invest. 2005 Jan;28(1):79-88. doi: 10.1007/BF03345534.
3
Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET.
在体外受精-胚胎移植(IVF-ET)控制性卵巢刺激之前,黄体中期给予促性腺激素释放激素激动剂(GnRHa)后雄激素和孕酮抑制不完全。
J Assist Reprod Genet. 1997 Oct;14(9):525-30. doi: 10.1023/a:1021179427139.